Go Pro

NervGen Pharma (NGENF) News Today

NervGen Pharma logo
$5.84 0.00 (0.00%)
As of 08/31/2026

NervGen Pharma Latest News

NervGen beruft Keith Vendola zum neuen Finanzvorstand
NervGen Pharma to Participate at Upcoming Investor Conferences
NervGen Pharma ernennt Dr. Adam Rogers zum CEO und President
NervGen Pharma Begins Trading on Nasdaq Today
NervGen Pharma Begins Trading on Nasdaq Today
NervGen Pharma Corp.
NervGen Pharma (NGENF) Gets a Buy from Raymond James
NervGen, Sprott Climb to 52-Week Highs on News
NervGen Pharma to Host Virtual Investor Event
NervGen Pharma price target raised to C$4.50 from C$3 at Raymond James
NervGen upgraded to Outperform from Market Perform at Raymond James
NervGen Pharma: Proof that NVG-291 works?
NervGen Pharma Nears Trial Enrollment Completion
NervGen Pharma Corp. (NGENF)
NervGen Completes $23 Million Bought Deal Financing
NERVGEN ANNOUNCES $20 MILLION BOUGHT DEAL OFFERING

NervGen Pharma Media Mentions By Week

NervGen Pharma Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NGENF
News Sentiment

0.00

0.93

Average
Healthcare
News Sentiment

NervGen Pharma News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NGENF Articles
This Week

0

0

NGENF Articles
Average Week

NervGen Pharma Trends on MarketBeat

This week vs. last week
Page Views
258
+141%
Get NervGen Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for NGENF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for NervGen Pharma dated 4/28/2026.
From Our Partners